Alto Neuroscience, Inc. (ANRO) Operating cash flow 2023–2025
Alto Neuroscience, Inc. (ANRO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$51.8MFY2025 · since FY2023: -$33.4M → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | -9.2% |
| FY2024 | -$47.4M | -41.8% |
| FY2023 | -$33.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANRO financial trends
ANRO RevenueANRO Net incomeANRO Net marginANRO Gross profitANRO Gross marginANRO Operating incomeANRO Operating marginANRO Free cash flowANRO Capital expendituresANRO Return on equityANRO Stock buybacksANRO Dividends paidANRO Total assetsANRO Total liabilitiesANRO Shareholders’ equityANRO overview →